RHHBY vs. ABBV: Which Stock Is the Better Value Option?
According to the average brokerage recommendation (ABR), one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
With this latest approval, JNJ's Tremfya is approved for a total of three immunology indications.